甲亚胺异丙酯 盐酸盐 | 16694-44-3

• 物质功能分类: 有机原料 - 氨基化合物 - 无环单胺、多胺及其衍生物和盐
• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 甲亚胺酸及其衍生物
• 中文名称: 甲亚胺异丙酯 盐酸盐
• 中文别名: 亚甲胺异丙酯盐酸盐；甲亚胺异丙酯盐酸盐
• 英文名称: isopropyl formimidate hydrochloride
• 英文别名: propan-2-yl methanimidate;hydrochloride
• CAS: 16694-44-3
• 化学式: C₄H₉NO*ClH
• mdl: MFCD00075345
• 分子量: 123.582
• InChiKey: NWCBOWOTHFLANG-UHFFFAOYSA-N

物化性质

• 熔点：
  108 °C (dec.)(lit.)
• 闪点：
  >230 °F
• 稳定性/保质期：
  按规定使用不会分解，需避免接触氧化剂、空气和水分。

计算性质

• 辛醇/水分配系数(LogP)：
  0.63
• 重原子数：
  7
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.75
• 拓扑面积：
  33.1
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xi
• 安全说明：
  S26,S36
• 危险类别码：
  R36
• WGK Germany：
  3
• 海关编码：
  2925290090
• 储存条件：
  存放于密闭、阴凉、干燥处。

SDS

---

Section 1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name : Isopropyl formimidate hydrochloride
CAS-No. : 16694-44-3

---

Section 2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Classification according to Regulation (EC) No 1272/2008 [EU-GHS/CLP]
Eye irritation (Category 2)
Classification according to EU Directives 67/548/EEC or 1999/45/EC
Irritating to eyes.
Label elements
Labelling according Regulation (EC) No 1272/2008 [CLP]
Pictogram
Signal word Warning
Hazard statement(s)
Causes serious eye irritation.
Precautionary statement(s)
P305 + P351 + P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove
contact lenses, if present and easy to do. Continue rinsing.
Supplemental Hazard none
Statements
According to European Directive 67/548/EEC as amended.
Hazard symbol(s)
R-phrase(s)
R36 Irritating to eyes.
S-phrase(s)
S26 In case of contact with eyes, rinse immediately with plenty of water and
seek medical advice.
Other hazards - none

---

Section 3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
Formula : C4H9NO · HCl
Molecular Weight : 123,58 g/mol
Component Concentration
Isopropyl formimidate hydrochloride
CAS-No. 16694-44-3 -

---

Section 4. FIRST AID MEASURES
Description of first aid measures
General advice
Consult a physician. Show this safety data sheet to the doctor in attendance.
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration. Consult a physician.
In case of skin contact
Wash off with soap and plenty of water. Consult a physician.
In case of eye contact
Rinse thoroughly with plenty of water for at least 15 minutes and consult a physician.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water. Consult a physician.
Most important symptoms and effects, both acute and delayed
Symptoms of exposure may include burning sensation, coughing, wheezing, laryngitis, shortness of breath,
headache, nausea, and vomiting., To the best of our knowledge, the chemical, physical, and toxicological
properties have not been thoroughly investigated.
Indication of any immediate medical attention and special treatment needed
no data available

---

Section 5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
no data available
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

---

Section 6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Use personal protective equipment. Avoid dust formation. Avoid breathing vapors, mist or gas. Ensure
adequate ventilation. Avoid breathing dust.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Pick up and arrange disposal without creating dust. Sweep up and shovel. Keep in suitable, closed
containers for disposal.
Reference to other sections
For disposal see section 13.

---

Section 7. HANDLING AND STORAGE
Precautions for safe handling
Avoid contact with skin and eyes. Avoid formation of dust and aerosols.
Provide appropriate exhaust ventilation at places where dust is formed.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Moisture sensitive.
Specific end use(s)
no data available

---

Section 8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
Handle in accordance with good industrial hygiene and safety practice. Wash hands before breaks and
at the end of workday.
Personal protective equipment
Eye/face protection
Safety glasses with side-shields conforming to EN166 Use equipment for eye protection tested
and approved under appropriate government standards such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Impervious clothing., The type of protective equipment must be selected according to the
concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
For nuisance exposures use type P95 (US) or type P1 (EU EN 143) particle respirator.For higher
level protection use type OV/AG/P99 (US) or type ABEK-P2 (EU EN 143) respirator cartridges.
Use respirators and components tested and approved under appropriate government standards
such as NIOSH (US) or CEN (EU).

---

Section 9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) Appearance Form: powder
Colour: white
b) Odour no data available
c) Odour Threshold no data available
d) pH no data available
e) Melting point/freezing Melting point/range: 108 °C - lit.
point
f) Initial boiling point and no data available
boiling range
g) Flash point 113 °C - closed cup
h) Evaporation rate no data available
i) Flammability (solid, gas) no data available
j) Upper/lower no data available
flammability or
explosive limits
k) Vapour pressure no data available
l) Vapour density no data available
m) Relative density no data available
n) Water solubility no data available
o) Partition coefficient: n- no data available
octanol/water
p) Auto-ignition no data available
temperature
q) Decomposition no data available
temperature
r) Viscosity no data available
s) Explosive properties no data available
t) Oxidizing properties no data available
Other safety information
no data available

---

Section 10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong oxidizing agents
Hazardous decomposition products
Other decomposition products - no data available

---

Section 11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
Carcinogenicity
IARC: No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
Inhalation
May be harmful if inhaled. May cause respiratory tract irritation.
Ingestion May be harmful if swallowed.
Skin May be harmful if absorbed through skin. May cause skin irritation.
Eyes Causes serious eye irritation.
Signs and Symptoms of Exposure
Symptoms of exposure may include burning sensation, coughing, wheezing, laryngitis, shortness of breath,
headache, nausea, and vomiting., To the best of our knowledge, the chemical, physical, and toxicological
properties have not been thoroughly investigated.
Additional Information
RTECS: Not available

---

Section 12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

---

Section 13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company. Dissolve or mix the material
with a combustible solvent and burn in a chemical incinerator equipped with an afterburner and scrubber.
Contaminated packaging
Dispose of as unused product.

---

Section 14. TRANSPORT INFORMATION
UN number
ADR/RID: - IMDG: - IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA: Not dangerous goods
Transport hazard class(es)
ADR/RID: - IMDG: - IATA: -
Packaging group
ADR/RID: - IMDG: - IATA: -
Environmental hazards
ADR/RID: no IMDG Marine Pollutant: no IATA: no
Special precautions for user
no data available

---

Section 15. REGULATORY INFORMATION
This safety datasheet complies with the requirements of Regulation (EC) No. 1907/2006.
Safety, health and environmental regulations/legislation specific for the substance or mixture
no data available
Chemical Safety Assessment

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  氟代乙酰氯 、 甲亚胺异丙酯 盐酸盐 在 三乙胺 作用下， 以 二氯甲烷 为溶剂， 以73%的产率得到N-fluoroacetyl isopropyl formimidate
  参考文献：
  名称：

  2-氮杂-1,3-二烯：合成方法和立体化学研究

  摘要：

  已经通过三种途径制备了在C-3处带有活化三烷基甲硅烷基氧基的2-Aza-1，3-二烯。第一条途径涉及N-酰基酰亚胺的甲硅烷基化，其可从亚氨基醚盐酸盐和酰氯容易获得。根据朝向这些双活化二烯的更通用的途径，通过在三乙胺的存在下与酰氯反应，将由不可烯化的醛衍生的N-三烷基甲硅烷基酰亚胺酯和N-三烷基甲硅烷基亚胺方便地以一锅法转化为相应的氮杂二烯。最后，可以通过在三乙胺的存在下用三烷基甲硅烷基三氟甲磺酸酯在两个氧上将戊二酰亚胺直接甲硅烷基化来制备环状二烯。2-氮二烯的构型和构象已由1 H，13确定C和15 N NMR光谱。

  DOI：

  10.1016/0040-4020(95)00657-t
• 作为产物：
  描述：

  异丙醇 、 formamide 在 苯甲酰氯 作用下， 以 乙醚 为溶剂， 反应 0.75h， 以90%的产率得到甲亚胺异丙酯 盐酸盐
  参考文献：
  名称：

  供体-受体环丙烷和氮杂二烯的(4+3)环化：氮杂环庚酮的高度立体选择性合成

  摘要：

  氮杂环庚酮是重要且广泛的七元杂环化合物，但其合成具有挑战性。依赖于氮杂二烯和供体-受体环丙烷的(4+3)环化反应开发了一种接近这些支架的收敛方法。使用Yb(OTf) 3作为催化剂实现了良好至优异的产率和高非对映选择性。在三恶唑啉 (Tox) 配体存在下，可以使用 Cu(OTf) 2进行不对称诱导。

  DOI：

  10.1002/anie.202209006

文献信息

• [EN] BETA-LACTAMASE INHIBITORS<br/>[FR] INHIBITEURS DE BÊTA-LACTAMASE
  申请人：VENATORX PHARMACEUTICALS INC

  公开号：WO2014089365A1

  公开（公告）日：2014-06-12

  Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

  本文描述了调节β-内酰胺酶活性的化合物和组合物。在某些实施例中，所述化合物抑制β-内酰胺酶。在特定实施例中，所述化合物在治疗细菌感染方面是有用的。
• [EN] BETA-LACTAMASE INHIBITORS<br/>[FR] INHIBITEURS DE BÊTA-LACTAMASES
  申请人：VENATORX PHARMACEUTICALS INC

  公开号：WO2017044828A1

  公开（公告）日：2017-03-16

  Described herein are compounds and compositions that modulate the activity of beta -lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.

  本发明描述了能够调节β-内酰胺酶活性的化合物和组合物。在某些实施例中，本发明所描述的化合物可抑制β-内酰胺酶。在某些实施例中，本发明所描述的化合物可用于治疗细菌感染。
• A Diels-Alder route towards pyrimidin-4-ones
  作者：Ph. Bayard、F. Sainte、R. Beaudegnies、L. Ghosez

  DOI：10.1016/s0040-4039(00)82118-8

  日期：1988.1

  N-acylimidates are readily silylated with t-butyldimethylsilyl triflate in the presence of triethylamine to give 2-aza-1,3-dienes . These react with activated nitriles to yield pyrimidin-4-ones .

  在三乙胺的存在下，N-酰基酰亚胺易于用三氟甲磺酸叔丁基二甲基甲硅烷基硅烷基化，得到2-氮杂-1,3-二烯。它们与活化的腈反应生成嘧啶-4-酮。
• Peptides—XI
  作者：M.T. Leplawy、D.S. Jones、G.W. Kenner、R.C. Sheppard

  DOI：10.1016/0040-4020(60)89006-0

  日期：1960.1

  Union of α-methylalanyl residues in a peptide chain is severely sterically hindered. This hindrance can be overcome by employing either the mixed anhydride (I) of pivalic acid and benzyloxycarbonyl-α-methylalanine or, more generally, oxazolones (II), including 4,4-dimethyl-2-trifluoromethyloxazolone (II; R = CF3). 4,4-Dimethyloxazolone (II; R = H) has been obtained in solution and characterized by

  肽链中的α-甲基丙氨酰基残基的结合受到严重的空间阻碍。可以通过使用新戊酸和苄氧羰基-α-甲基丙氨酸的混合酸酐（I）或更普遍地使用恶唑酮（II），包括4,4-二甲基-2-三氟甲基恶唑酮（II； R = CF 3）来克服这一障碍。）。在溶液中获得了4,4-二甲基恶唑酮（II； R = H），并通过红外光谱对其进行了表征；与在羰基上与环己胺的正常反应相反，它在次甲基上被α-甲基丙氨酸甲酯攻击。
• Process for the preparation of N-protected N-formimidoyl
  申请人：Merck & Co., Inc.

  公开号：US04292436A1

  公开（公告）日：1981-09-29

  Disclosed is 2 and a process for its preparation: ##STR1## It is useful in the synthesis of N-formimidoyl thienamycin; R.sup.2 is hydrogen or a protecting group.

  公开了2及其制备方法：##STR1##它在N-甲酰基噻呤霉素的合成中有用；R.sup.2是氢或保护基。